Recognizing representatives from industry, patient advocacy, government and more who are
leading the way in the orphan drug community
This report recognizes the top 50 thought-leaders in orphan drugs and rare disease. Thought-leaders include representatives from industry, patient advocacy groups, research institutions, government and media from around the world.
They were selected based on the following criteria:
-
Research & methodology
-
Leadership
-
Awards & recognition
-
Community engagement & impact
Download a copy of the report today to find out who is pioneering orphan drug research, awareness and legislation.